People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health.
source https://www.pharmatutor.org/pharma-news/2021/covid-19-outcomes-for-patients-on-immunosuppressive-drugs-on-par-with-non-immunosuppressed-patients
No comments:
Post a Comment